Literature DB >> 33307932

Framing a Consent Form to Improve Consent Understanding and Determine How This Affects Willingness to Participate in HIV Cure Research: An Experimental Survey Study.

John A Sauceda1, Karine Dubé2, Brandon Brown3, Ashley E Pérez1, Catherine E Rivas1, David Evans4, Celia B Fisher5.   

Abstract

HIV cure research carries serious risks and negligible benefits. We investigated how participants understand these risks and what influences their willingness to participate. Through internet-based and in-person convenience sampling, 86 HIV+ participants completed an experimental survey. Participants were randomized to read a standard consent form describing a hypothetical HIV cure study or one adapted using Fuzzy Trace Theory-a decision-making model to facilitate complex information processing. We measured consent understanding and cognitive (e.g., safe/harmful) and affective (e.g., concerning, satisfying) evaluations of HIV cure research. Participants who read the adapted consent form had improved consent understanding, but only positive affective evaluations were associated with a willingness to participate. Consent processes can use decision-making theories to facilitate comprehension of study information.

Entities:  

Keywords:  HIV continuum; HIV cure research; fuzzy-trace theory; informed consent; recruitment

Mesh:

Year:  2020        PMID: 33307932      PMCID: PMC8035136          DOI: 10.1177/1556264620981205

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.978


  32 in total

1.  A measure of informed choice.

Authors:  T M Marteau; E Dormandy; S Michie
Journal:  Health Expect       Date:  2001-06       Impact factor: 3.377

2.  A new brief instrument for assessing decisional capacity for clinical research.

Authors:  Dilip V Jeste; Barton W Palmer; Paul S Appelbaum; Shahrokh Golshan; Danielle Glorioso; Laura B Dunn; Kathleen Kim; Thomas Meeks; Helena C Kraemer
Journal:  Arch Gen Psychiatry       Date:  2007-08

3.  "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.

Authors:  Karine Dubé; David Evans; Lynda Dee; Laurie Sylla; Jeff Taylor; Asheley Skinner; Bryan J Weiner; Sandra B Greene; Stuart Rennie; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2017-07-10       Impact factor: 2.205

4.  International AIDS Society global scientific strategy: towards an HIV cure 2016.

Authors:  Steven G Deeks; Sharon R Lewin; Anna Laura Ross; Jintanat Ananworanich; Monsef Benkirane; Paula Cannon; Nicolas Chomont; Daniel Douek; Jeffrey D Lifson; Ying-Ru Lo; Daniel Kuritzkes; David Margolis; John Mellors; Deborah Persaud; Joseph D Tucker; Françoise Barre-Sinoussi; Galit Alter; Judith Auerbach; Brigitte Autran; Dan H Barouch; Georg Behrens; Marina Cavazzana; Zhiwei Chen; Éric A Cohen; Giulio Maria Corbelli; Serge Eholié; Nir Eyal; Sarah Fidler; Laurindo Garcia; Cynthia Grossman; Gail Henderson; Timothy J Henrich; Richard Jefferys; Hans-Peter Kiem; Joseph McCune; Keymanthri Moodley; Peter A Newman; Monique Nijhuis; Moses Supercharger Nsubuga; Melanie Ott; Sarah Palmer; Douglas Richman; Asier Saez-Cirion; Matthew Sharp; Janet Siliciano; Guido Silvestri; Jerome Singh; Bruno Spire; Jeffrey Taylor; Martin Tolstrup; Susana Valente; Jan van Lunzen; Rochelle Walensky; Ira Wilson; Jerome Zack
Journal:  Nat Med       Date:  2016-07-11       Impact factor: 53.440

5.  Unintended HIV-1 Infection During Analytical Therapy Interruption.

Authors:  Ainoa Ugarte; Yolanda Romero; Amparo Tricas; Concepcion Casado; Cecilio Lopez-Galindez; Felipe Garcia; Lorna Leal
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

6.  Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation.

Authors:  Susan P Buchbinder; Barbara Metch; Sarah E Holte; Susan Scheer; Anne Coletti; Eric Vittinghoff
Journal:  J Acquir Immune Defic Syndr       Date:  2004-05-01       Impact factor: 3.731

7.  Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis.

Authors:  Adam Gilbertson; Elizabeth Poole Kelly; Stuart Rennie; Gail Henderson; JoAnn Kuruc; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-22       Impact factor: 2.205

8.  Monetary incentives improve recall of research consent information: it pays to remember.

Authors:  David S Festinger; Douglas B Marlowe; Jason R Croft; Karen L Dugosh; Patricia L Arabia; Kathleen M Benasutti
Journal:  Exp Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.157

9.  Risk and radical uncertainty in HIV research.

Authors:  Caspar Hare
Journal:  J Med Ethics       Date:  2016-09-26       Impact factor: 2.903

Review 10.  Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.

Authors:  Karine Dubé; Judith D Auerbach; Michael J Stirratt; Paul Gaist
Journal:  J Int AIDS Soc       Date:  2019-10       Impact factor: 5.396

View more
  2 in total

1.  Navigating ethical challenges of conducting randomized clinical trials on COVID-19.

Authors:  Dan Kabonge Kaye
Journal:  Philos Ethics Humanit Med       Date:  2022-01-28       Impact factor: 2.464

Review 2.  Ethics of HIV cure research: an unfinished agenda.

Authors:  Karine Dubé; John Kanazawa; Jeff Taylor; Lynda Dee; Nora Jones; Christopher Roebuck; Laurie Sylla; Michael Louella; Jan Kosmyna; David Kelly; Orbit Clanton; David Palm; Danielle M Campbell; Morénike Giwa Onaiwu; Hursch Patel; Samuel Ndukwe; Laney Henley; Mallory O Johnson; Parya Saberi; Brandon Brown; John A Sauceda; Jeremy Sugarman
Journal:  BMC Med Ethics       Date:  2021-06-30       Impact factor: 2.834

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.